Sun Pharma Advanced Research Company Limited (SPARC) — Cash Flow Quality Index
Sun Pharma Advanced Research Company Limited (SPARC) has a Cash Flow Quality Index of 0.62x as of December 2022. Operating cash flow of Rs62.60 Million is below net income of Rs101.50 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SPARC strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sun Pharma Advanced Research Company Limited Cash Flow Quality Index (2014–2014)
Historical Cash Flow Quality Index for Sun Pharma Advanced Research Company Limited across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Sun Pharma Advanced Research Company Lim to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sun Pharma Advanced Research Company Limited (2014–2014)
Year-by-year earnings quality comparison for Sun Pharma Advanced Research Company Limited. For live market cap and the full company financial profile, see Sun Pharma Advanced Research Company Lim (SPARC) market capitalisation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.07x | Rs368.95 Million | Rs343.24 Million | — |